# Protect the Head to Head Study

> **NCT05684146** · PHASE2 · UNKNOWN · sponsor: **Emboline** · enrollment: 540 (estimated)

## Conditions studied

- Embolism

## Interventions

- **DEVICE:** Emboliner Embolic Protection
- **DEVICE:** Sentinel Cerebral Protection

## Key facts

- **NCT ID:** NCT05684146
- **Lead sponsor:** Emboline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-04
- **Primary completion:** 2024-10
- **Final completion:** 2024-12
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2023-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05684146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05684146, "Protect the Head to Head Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05684146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
